Dr. Jokūbas Žiburkus is a neuroscientist with over 20 peer-reviewed publications and book chapters. He is Co-Founder/CEO of Canntelligence, cannabinoid education and research company located at the University of Houston Innovation Center. Dr. Žiburkus is conducting research on epilepsy and
Alzheimer’s disease with a current focus on cannabinoid actions in the brain and novel treatments for neurological disorders. Žiburkus is a recipient of the Global Lithuanian Leader Award for intellectual capital dissemination and is a recognized public speaker with a widely watched Tedx Talk entitled, “There is something you should know about epilepsy and cannabis.” Žiburkus has a proven track record of international leadership and strategic planning, and currently serves on several prestigious medical advisory boards, including Dravet Syndrome Foundation’s Scientific and Medical Advisory Board. Dr.Žiburkus completed his PhD in Louisiana State University Health Sciences Center and his postdoctorate fellowships at Johns Hopkins University Zanvyl Krieger Mind/Brain Institute and George Mason University Krasnow Institute for Advanced Studies.